Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sawdey

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitorT Ny, M Sawdey, D Lawrence, et al.
The American Journal of Pathology|September 1, 1993
Type 1 plasminogen activator inhibitor gene expression following partial hepatectomyJ Schneiderman, M Sawdey, H Craig, et al.
Annals of the New York Academy of Sciences|April 18, 1994
Analysis of PAI-1 gene expression in vivo using in situ hybridizationD J Loskutoff, M Sawdey, M Keeton, et al.
Journal of Immunological Methods|September 30, 1994
Immunization with plasmid DNA using a pneumatic gunH L Vahlsing, M A Yankauckas, M Sawdey, et al.
The Journal of Biological Chemistry|April 25, 1988
Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitorR R Schleef, M P Bevilacqua, M Sawdey, et al.
Oral Diseases|December 13, 2002
Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responsesV Sankar, L Baccaglini, M Sawdey, et al.
The Journal of Biological Chemistry|March 5, 1988
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cellsJ Keski-Oja, R Raghow, M Sawdey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188J Hartikka, L Sukhu, C Buchner, et al.
Vaccine|March 3, 2001
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigensJ Hartikka, V Bozoukova, M Ferrari, et al.
Human Gene Therapy|June 20, 1996
An improved plasmid DNA expression vector for direct injection into skeletal muscleJ Hartikka, M Sawdey, F Cornefert-Jensen, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitorT Ny, M Sawdey, D Lawrence, et al.
The American Journal of Pathology|September 1, 1993
Type 1 plasminogen activator inhibitor gene expression following partial hepatectomyJ Schneiderman, M Sawdey, H Craig, et al.
Annals of the New York Academy of Sciences|April 18, 1994
Analysis of PAI-1 gene expression in vivo using in situ hybridizationD J Loskutoff, M Sawdey, M Keeton, et al.
Journal of Immunological Methods|September 30, 1994
Immunization with plasmid DNA using a pneumatic gunH L Vahlsing, M A Yankauckas, M Sawdey, et al.
The Journal of Biological Chemistry|April 25, 1988
Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitorR R Schleef, M P Bevilacqua, M Sawdey, et al.
Oral Diseases|December 13, 2002
Salivary gland delivery of pDNA-cationic lipoplexes elicits systemic immune responsesV Sankar, L Baccaglini, M Sawdey, et al.
The Journal of Biological Chemistry|March 5, 1988
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cellsJ Keski-Oja, R Raghow, M Sawdey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188J Hartikka, L Sukhu, C Buchner, et al.
Vaccine|March 3, 2001
Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigensJ Hartikka, V Bozoukova, M Ferrari, et al.
Human Gene Therapy|June 20, 1996
An improved plasmid DNA expression vector for direct injection into skeletal muscleJ Hartikka, M Sawdey, F Cornefert-Jensen, et al.
Pageof 3